Evidence map›Paper›PMID 36998597›Full record

ArticleFrontiers in surgery2023

Expression of hypoxia-inducing factor-1

Mingrui Luo, Jin Yu, Can Xin, Miao Hu, Tianshu Tao, Guiping Wan, Jincao Chen, Jianjian Zhang

Open access · goldFull text read
In one paragraph

Article in Frontiers in surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mingrui LuoDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jin YuDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Can XinDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Miao HuDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Tianshu TaoDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Guiping WanDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jincao ChenDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jianjian ZhangDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In our latest research, we have demonstrated that the recipient parasylvian cortical arteries (PSCAs) with hemodynamic sources from the middle cerebral artery (M-PSCAs) has a higher risk of postoperative cerebral hyperperfusion (CHP) syndrome than those from non-M-PSCAs in adult moyamoya disease (MMD) patient. However, whether there are differences between M-PSCAs and non-M-PSCAs in vascular specimens characteristics has not been studied. In this study, we further investigate the vascular specimen of recipient PSCAs by histological and immunohistochemical methods. Methods: 50 vascular specimens of recipient PSCAs were obtained from 50 adult MMD patients during the combined bypass surgeries in our departments of Zhongnan hospital. 4 recipient PSCAs samples were also obtained in the same way from the middle cerebral artery occlusion patients. The samples were received the pathological sectioning, hematoxylin and eosin staining, and immunohistochemistry, then the vascular wall thickness, matrix metalloproteinase-9 (MMP-9) and hypoxia-inducing factor-1 Results: M-PSCAs adult MMD patients had a thinner intima than non-M-PSCAs in the recipient PSCAs specimens. In recipient non-M-PSCAs vascular specimens, the immunoreactivity indicating HIF-1 Conclusion: Our results indicate that M-PSCAs adult MMD patients had thinner intima than non-MCAs adult MMD patients in the PSCAs. More importantly, HIF-1

Indexed as

cerebral hyperperfusion syndromehypoxia-inducing factor-1αintimamatrix metalloproteinase-9moyamoya disease

Identifiers

PMID36998597
PMCPMC10043197
OpenAlexW4324145596

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.